173 related articles for article (PubMed ID: 38286463)
21. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia.
Xia J; Bolyard AA; Rodger E; Stein S; Aprikyan AA; Dale DC; Link DC
Br J Haematol; 2009 Nov; 147(4):535-42. PubMed ID: 19775295
[TBL] [Abstract][Full Text] [Related]
22. A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome.
McDermott DH; Velez D; Cho E; Cowen EW; DiGiovanna JJ; Pastrana DV; Buck CB; Calvo KR; Gardner PJ; Rosenzweig SD; Stratton P; Merideth MA; Kim HJ; Brewer C; Katz JD; Kuhns DB; Malech HL; Follmann D; Fay MP; Murphy PM
J Clin Invest; 2023 Oct; 133(19):. PubMed ID: 37561579
[TBL] [Abstract][Full Text] [Related]
23. Case Report: Characterization of known (c.607G>C) and novel (c.416C>G)
Núñez-Núñez ME; Lona-Reyes JC; López-Barragán B; Cruz-Osorio RM; Gutiérrez-Zepeda BM; Quintero-Ramos A; Becerra-Loaiza DS
Front Immunol; 2023; 14():1194262. PubMed ID: 37795094
[TBL] [Abstract][Full Text] [Related]
24. Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors.
Aprikyan AA; Liles WC; Park JR; Jonas M; Chi EY; Dale DC
Blood; 2000 Jan; 95(1):320-7. PubMed ID: 10607719
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia.
Welte K; Zeidler C; Reiter A; Müller W; Odenwald E; Souza L; Riehm H
Blood; 1990 Mar; 75(5):1056-63. PubMed ID: 1689595
[TBL] [Abstract][Full Text] [Related]
26. Novel ELANE gene mutation in a Korean girl with severe congenital neutropenia.
Shim YJ; Kim HJ; Suh JS; Lee KS
J Korean Med Sci; 2011 Dec; 26(12):1646-9. PubMed ID: 22148006
[TBL] [Abstract][Full Text] [Related]
27. Kostmann's Disease and HCLS1-Associated Protein X-1 (HAX1).
Klein C
J Clin Immunol; 2017 Feb; 37(2):117-122. PubMed ID: 27943080
[TBL] [Abstract][Full Text] [Related]
28. Severe congenital neutropenia.
Welte K; Zeidler C
Hematol Oncol Clin North Am; 2009 Apr; 23(2):307-20. PubMed ID: 19327585
[TBL] [Abstract][Full Text] [Related]
29. New insights into the pathomechanism of cyclic neutropenia.
Mir P; Klimiankou M; Findik B; Hähnel K; Mellor-Heineke S; Zeidler C; Skokowa J; Welte K
Ann N Y Acad Sci; 2020 Apr; 1466(1):83-92. PubMed ID: 32083314
[TBL] [Abstract][Full Text] [Related]
30. Severe congenital neutropenia unresponsive to G-CSF.
Ryan M; Will AM; Testa N; Hayworth C; Darbyshire PJ
Br J Haematol; 1995 Sep; 91(1):43-5. PubMed ID: 7577650
[TBL] [Abstract][Full Text] [Related]
31. Four novel ELANE mutations in patients with congenital neutropenia.
Kurnikova M; Maschan M; Dinova E; Shagina I; Finogenova N; Mamedova E; Polovtseva T; Shagin D; Shcherbina A
Pediatr Blood Cancer; 2011 Aug; 57(2):332-5. PubMed ID: 21425445
[TBL] [Abstract][Full Text] [Related]
32. Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia.
Mempel K; Pietsch T; Menzel T; Zeidler C; Welte K
Blood; 1991 May; 77(9):1919-22. PubMed ID: 1708293
[TBL] [Abstract][Full Text] [Related]
33. Contrasting effects of recombinant human granulocyte-macrophage colony-stimulating factor (CSF) and granulocyte CSF treatment on the cycling of blood elements in childhood-onset cyclic neutropenia.
Wright DG; Kenney RF; Oette DH; LaRussa VF; Boxer LA; Malech HL
Blood; 1994 Aug; 84(4):1257-67. PubMed ID: 7519479
[TBL] [Abstract][Full Text] [Related]
34. Game of clones: the genomic evolution of severe congenital neutropenia.
Touw IP
Hematology Am Soc Hematol Educ Program; 2015; 2015():1-7. PubMed ID: 26637693
[TBL] [Abstract][Full Text] [Related]
35. Homozygous c.130-131 ins A (pW44X) mutation in the HAX1 gene as the most common cause of congenital neutropenia in Turkey: Report from the Turkish Severe Congenital Neutropenia Registry.
Yılmaz Karapınar D; Patıroğlu T; Metin A; Çalışkan Ü; Celkan T; Yılmaz B; Karakaş Z; Karapınar TH; Akıncı B; Özkınay F; Onay H; Yeşilipek MA; Akar HH; Tüysüz G; Tokgöz H; Özdemir GN; Aslan Kıykım A; Karaman S; Kılınç Y; Oymak Y; Küpesiz A; Olcay L; Keskin Yıldırım Z; Aydoğan G; Gökçe M; İleri T; Aral YZ; Bay A; Atabay B; Kaya Z; Söker M; Özdemir Karadaş N; Özbek U; Özsait Selçuk B; Özdemir HH; Uygun V; Tezcan Karasu G; Yılmaz Ş
Pediatr Blood Cancer; 2019 Oct; 66(10):e27923. PubMed ID: 31321910
[TBL] [Abstract][Full Text] [Related]
36. Clinical relevance of SCN and CyN induced by ELANE mutations: a systematic review.
Xiao Y; Wang N; Jin X; Liu A; Zhang Z
Front Immunol; 2024; 15():1349919. PubMed ID: 38840904
[TBL] [Abstract][Full Text] [Related]
37. Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF-triggered granulopoiesis.
Skokowa J; Klimiankou M; Klimenkova O; Lan D; Gupta K; Hussein K; Carrizosa E; Kusnetsova I; Li Z; Sustmann C; Ganser A; Zeidler C; Kreipe HH; Burkhardt J; Grosschedl R; Welte K
Nat Med; 2012 Oct; 18(10):1550-9. PubMed ID: 23001182
[TBL] [Abstract][Full Text] [Related]
38. HAX1 mutation in an infant with severe congenital neutropenia.
Eghbali A; Eshghi P; Malek F; Abdollahpour H; Rezaei N
Turk J Pediatr; 2010; 52(1):81-4. PubMed ID: 20402072
[TBL] [Abstract][Full Text] [Related]
39. Combined corticosteroid/granulocyte colony-stimulating factor (G-CSF) therapy in the treatment of severe congenital neutropenia unresponsive to G-CSF: Activated glucocorticoid receptors synergize with G-CSF signals.
Dror Y; Ward AC; Touw IP; Freedman MH
Exp Hematol; 2000 Dec; 28(12):1381-9. PubMed ID: 11146160
[TBL] [Abstract][Full Text] [Related]
40. Severe congenital neutropenia.
Welte K; Zeidler C; Dale DC
Semin Hematol; 2006 Jul; 43(3):189-95. PubMed ID: 16822461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
